Literature DB >> 1280833

Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor.

L Bangalore1, A J Tanner, A P Laudano, D F Stern.   

Abstract

Rabbits were immunized with a synthetic phosphopeptide corresponding to a major autophosphorylation site of p185neu/erbB2 to determine the feasibility of producing tyrosine-phosphopeptide-specific antibodies. A series of adsorption and affinity chromatography steps were used to select antibodies with the desired reactivity. Immunoblot experiments showed that the resulting serum is highly specific for tyrosine-phosphorylated forms of p185 and the related epidermal growth factor receptor. The serum recognized these two receptors selectively when compared to five other receptor tyrosine kinases and several phosphorylated substrates. The serum is compatible with tissue-based assays since it detected tyrosine phosphorylation of the epidermal growth factor receptor in immunofluorescence experiments on permeabilized cells. The generality of the procedures used means that similar anti-tyrosine phosphopeptide sera can be produced that recognize other tyrosine kinases and substrates. Such sera will have numerous applications in research and clinical settings.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280833      PMCID: PMC50608          DOI: 10.1073/pnas.89.23.11637

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

Review 1.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Tyr527 is phosphorylated in pp60c-src: implications for regulation.

Authors:  J A Cooper; K L Gould; C A Cartwright; T Hunter
Journal:  Science       Date:  1986-03-21       Impact factor: 47.728

3.  Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.

Authors:  L R Rohrschneider; V M Rothwell; N A Nicola
Journal:  Oncogene       Date:  1989-08       Impact factor: 9.867

4.  c-erbB-2 oncoprotein expression in primary human tumors.

Authors:  A McCann; P A Dervan; P A Johnston; W J Gullick; D N Carney
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

5.  Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit.

Authors:  J R Flores-Riveros; E Sibley; T Kastelic; M D Lane
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

Review 6.  Follow-up study of HER-2/neu amplification in primary breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

7.  Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

Authors:  M P Kamps; B M Sefton
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

8.  Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis.

Authors:  K L Gould; P Nurse
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

9.  p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.

Authors:  D F Stern; P A Heffernan; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

10.  Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.

Authors:  L Petti; L A Nilson; D DiMaio
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  14 in total

1.  Extracting functional information from tissues.

Authors:  M P DiGiovanna
Journal:  Mol Diagn       Date:  2001-03

2.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus.

Authors:  E Pinter; M Barreuther; T Lu; B A Imhof; J A Madri
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

Authors:  James W Mandell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

4.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056.

Authors:  Richard M Gallo; David J Riese
Journal:  Growth Factors       Date:  2007-10       Impact factor: 2.511

6.  Activation of ErbB2 during wallerian degeneration of sciatic nerve.

Authors:  Y K Kwon; A Bhattacharyya; J A Alberta; W V Giannobile; K Cheon; C D Stiles; S L Pomeroy
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.

Authors:  A Bishayee; L Beguinot; S Bishayee
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

8.  Directed evolution of the forkhead-associated domain to generate anti-phosphospecific reagents by phage display.

Authors:  Kritika Pershad; Karolina Wypisniak; Brian K Kay
Journal:  J Mol Biol       Date:  2012-09-15       Impact factor: 5.469

9.  Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.

Authors:  S S Bacus; D Chin; Y Yarden; C R Zelnick; D F Stern
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.

Authors:  M P Coghlan; T S Pillay; J M Tavaré; K Siddle
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.